|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM119485923 |
| 003 |
DE-627 |
| 005 |
20231222184847.0 |
| 007 |
tu |
| 008 |
231222s2002 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0399.xml
|
| 035 |
|
|
|a (DE-627)NLM119485923
|
| 035 |
|
|
|a (NLM)12075966
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Kripfgans, Oliver D
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a In vivo droplet vaporization for occlusion therapy and phase aberration correction
|
| 264 |
|
1 |
|c 2002
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 09.08.2002
|
| 500 |
|
|
|a Date Revised 16.09.2019
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a The objective was to determine whether a transpulmonary droplet emulsion (90%, <6 microm diameter) could be used to form large gas bubbles (>30 microm) temporarily in vivo. Such bubbles could occlude a targeted capillary bed when used in a large number density. Alternatively, for a very sparse population of droplets, the resulting gas bubbles could serve as point beacons for phase aberration corrections in ultrasonic imaging. Gas bubbles can be made in vivo by acoustic droplet vaporization (ADV) of injected, superheated, dodecafluoropentane droplets. Droplets vaporize in an acoustic field whose peak rarefactional pressure exceeds a well-defined threshold. In this new work, it has been found that intraarterial and intravenous injections can be used to introduce the emulsion into the blood stream for subsequent ADV (B- and M-mode on a clinical scanner) in situ. Intravenous administration results in a lower gas bubble yield, possibly because of filtering in the lung, dilution in the blood volume, or other circulatory effects. Results show that for occlusion purposes, a reduction in regional blood flow of 34% can be achieved. Individual point beacons with a +24 dB backscatter amplitude relative to white matter were created by intravenous injection and ADV
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, U.S. Gov't, Non-P.H.S.
|
| 650 |
|
4 |
|a Research Support, U.S. Gov't, P.H.S.
|
| 650 |
|
7 |
|a Albumins
|2 NLM
|
| 650 |
|
7 |
|a Contrast Media
|2 NLM
|
| 650 |
|
7 |
|a Emulsions
|2 NLM
|
| 650 |
|
7 |
|a Fluorocarbons
|2 NLM
|
| 700 |
1 |
|
|a Fowlkes, J Brian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Woydt, Michael
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Eldevik, Odd P
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Carson, Paul L
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t IEEE transactions on ultrasonics, ferroelectrics, and frequency control
|d 1986
|g 49(2002), 6 vom: 25. Juni, Seite 726-38
|w (DE-627)NLM098181017
|x 1525-8955
|7 nnns
|
| 773 |
1 |
8 |
|g volume:49
|g year:2002
|g number:6
|g day:25
|g month:06
|g pages:726-38
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 49
|j 2002
|e 6
|b 25
|c 06
|h 726-38
|